Big Gain For Evofem Biosciences, Inc.
Evofem Biosciences, Inc. (EVFM:NASDAQ) jumped higher at $0.04, representing a gain of 32.7%. On Wed, Mar 22, 2023, EVFM:NASDAQ hit a New 2-Week High of $0.04. The stock appeared on our News Catalysts scanner on Mon, Feb 27, 2023 at 08:39 AM in the 'BIOTECH' category. From Wed, Mar 08, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- Zura Bio Limited (ZURA:NASDAQ), 307.61%
- Maxpro Capital Acquisition Corp. (JMAC:NASDAQ), 56.84%
- Boxed Inc. (BOXD:NYSE), 49.92%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 38.7%
- GameStop Corp. (GME:NYSE), 35.24%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 33.65%
- Virgin Orbit Holdings Inc. (VORB:NASDAQ), 33.12%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 32.73%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 29.6%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 28.21%